advanced malignant tumor
Showing 1 - 14 of 14
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Advanced Malignant Tumor Trial in Jinan (JS207)
Not yet recruiting
- Advanced Malignant Tumor
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023
Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)
Recruiting
- Advanced Malignant Tumor
- BAT7104 injection
-
Guangzhou, Guangdong, ChinaLi Zhang
Mar 1, 2023
Advanced Malignant Tumor Trial in Zhengzhou (HRS2398 Tablets)
Recruiting
- Advanced Malignant Tumor
- HRS2398 Tablets
-
Zhengzhou, Henan, ChinaAffiliated Cancer Hospital of Zhengzhou University/Henan Cancer
Aug 2, 2022
Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)
Recruiting
- Advanced Malignant Tumor
- TQB3915 tablets
-
Guangzhou, Guangdong, China
- +2 more
Jun 9, 2022
Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)
Recruiting
- Advanced Malignant Tumor
- TQB3909 Tablets
-
Nanjing, Jiangsu, China
- +1 more
Mar 3, 2022
Advanced Malignant Tumor Trial (Mitoxantrone Hydrochloride Liposome)
Not yet recruiting
- Advanced Malignant Tumor
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
Oct 9, 2021
Advanced Malignant Tumor Trial in Nanjing (QLS31901)
Recruiting
- Advanced Malignant Tumor
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Sep 13, 2021
Advanced Malignant Tumor Trial in Guangzhou (SH3765 tablet)
Not yet recruiting
- Advanced Malignant Tumor
- SH3765 tablet
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 18, 2021
Advanced Malignant Tumor Trial in Shanghai (Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant
Recruiting
- Advanced Malignant Tumor
- Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)
-
Shanghai, Shanghai, ChinaDragonboat Biopharmaceutical,Co.,Ltd
Feb 3, 2021
Advanced Malignant Tumor Trial in Guangzhou (QL1706)
Unknown status
- Advanced Malignant Tumor
- QL1706
-
Guangzhou, Guangdong, ChinaSun Yat-sen Univeisity Cancer Center
Mar 3, 2020